Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:NHWK

NightHawk Biosciences (NHWK) Stock Price, News & Analysis

NightHawk Biosciences logo

About NightHawk Biosciences Stock (NYSE:NHWK)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.26
$0.50
52-Week Range
N/A
Volume
173,100 shs
Average Volume
97,242 shs
Market Capitalization
$10.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NHWK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NightHawk Biosciences and its competitors with MarketBeat's FREE daily newsletter.

NHWK Stock News Headlines

SCPXD Scorpius Holdings, Inc.
Scorpius Holdings GAAP EPS of -$1.74
Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.
See More Headlines

NHWK Stock Analysis - Frequently Asked Questions

NightHawk Biosciences, Inc. (NYSE:NHWK) issued its quarterly earnings results on Tuesday, November, 9th. The biopharmaceutical company reported ($0.30) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.29) by $0.01. The biopharmaceutical company earned $0.50 million during the quarter, compared to the consensus estimate of $0.57 million. NightHawk Biosciences had a negative net margin of 2,333.27% and a negative trailing twelve-month return on equity of 91.62%.

NightHawk Biosciences's stock reverse split on the morning of Friday, December 11th 2020.The 1-7 reverse split was announced on Thursday, December 10th 2020. The number of shares owned by shareholders was adjusted after the market closes on Friday, December 11th 2020. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that NightHawk Biosciences investors own include Inovio Pharmaceuticals (INO), Sorrento Therapeutics (SRNE), Meta Platforms (META), Vaxart (VXRT), Alibaba Group (BABA), NVIDIA (NVDA) and Novavax (NVAX).

Company Calendar

Last Earnings
11/09/2021
Today
7/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NYSE:NHWK
CIK
1476963
Fax
N/A
Employees
77
Year Founded
2008

Profitability

EPS (Trailing Twelve Months)
($1.99)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$43.44 million
Net Margins
-2,333.27%
Pretax Margin
-2,546.97%
Return on Equity
-91.62%
Return on Assets
-56.48%

Debt

Debt-to-Equity Ratio
0.27
Current Ratio
0.99
Quick Ratio
0.99

Sales & Book Value

Annual Sales
$6.38 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.82 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
26,080,000
Free Float
21,935,000
Market Cap
$10.78 million
Optionable
Optionable
Beta
0.19

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NYSE:NHWK) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners